Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 3 clinical trials
Intravesical Gemcitabine and Docetaxel for BCG na ve Non-muscle Invasive Bladder Cancer

, randomized phase 3 trial comparing the experimental combination therapy and standard of care intravesical BCG therapy.

carcinoma
carcinoma in situ
intravesical bcg therapy
cancer
gemcitabine
  • 0 views
  • 25 Jan, 2021
  • 1 location
ADAPT-BLADDER: Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder

re-treatment with intravesical BCG therapy would be considered.

durvalumab
neutrophil count
intravesical bcg therapy
carcinoma
transitional cell carcinoma
  • 47 views
  • 25 Jan, 2021
  • 11 locations
Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer

This phase II trial studies the safety and feasibility of utilizing acupuncture in patients with high-risk bladder cancer that has not spread to the surrounding muscle (non-muscle invasive) undergoing treatment with Intravesical BCG. BCG is a weakened form of the bacterium Mycobacterium bovis that does not cause disease. It is …

  • 0 views
  • 18 Feb, 2021
  • 1 location